In HTLV-1 endemic areas, 5 to 10% of HIV-1-infected individuals are also coinfected with HTLV-1/2. Several studies support the finding that dual infection of HIV-1 and HTLV-2 may confer delayed AIDS progression. In contrast, HTLV-1 has been concluded to have either no effect or to increase progression to AIDS in HIV-1-infected individuals. Although Tax-1 is known to influence HIV-1 replication in vitro, other HTLV-1 proteins likely have a role in retroviral coinfection. Here, we are investigating whether HTLV-1 proteins regulate activation of HIV-1 expression in latently-infected cells. In this study, we used B-cells infected with molecular clones that either express both p12 and p8, p12-only, p8-only, or contain knockouts to orf-I, orf-II, or hbz. The HTLV-1-infected B-cells were cocultured with KK1 T-cells latently-infected with HIV-1. Following coculture, cells and media were assayed for viral expression. Analyses of immunoblot and ELISA data suggest that HTLV-1-infected B-cells that express p8 enhanced activation of latent HIV-1 expression. We are currently examining whether cell-to-cell contact with p8 expressing cells is required to reactivate the latently-infected KK1 cells. Results from this study could have an impact on treatment of patients coinfected with HIV-1 and HTLV-1.
. 2014 Jan 7;11(Suppl 1):P122. doi: 10.1186/1742-4690-11-S1-P122
Role of regulatory proteins in HIV-1/HTLV-1 coinfection
Dustin Edwards
1, Klaus Strebel
2, Robyn Washington Parks
1, Cynthia Pise-Masison
1, Claudio Fenizia
1, Martina Fiocchi
1, Genoveffa Franchini
1,✉
Dustin Edwards
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Find articles by Dustin Edwards
Klaus Strebel
2Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Find articles by Klaus Strebel
Robyn Washington Parks
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Find articles by Robyn Washington Parks
Cynthia Pise-Masison
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Find articles by Cynthia Pise-Masison
Claudio Fenizia
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Find articles by Claudio Fenizia
Martina Fiocchi
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Find articles by Martina Fiocchi
Genoveffa Franchini
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Find articles by Genoveffa Franchini
1Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
2Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
✉
Corresponding author.
Supplement
16th International Conference on Human Retroviruses: HTLV and Related Viruses
Benoit Barbeau
Conference
26-30 June 2013
16th International Conference on Human Retroviruses: HTLV and Related Viruses
Montreal, Canada
Collection date 2014.
Copyright © 2014 Edwards et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
PMCID: PMC4043673
